Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Synthesis and biological evaluation of nectriatide derivatives, potentiators of amphotericin B activity

Abstract

Nectriatide 1a, a naturally occurring cyclic tetrapeptide, has been reported to a potentiator of amphotericin B (AmB) activity. In order to elucidate its structure-activity relationships, we synthesized nectriatide derivatives with different amino acids in solution-phase synthesis and evaluated AmB-potentiating activity against Candida albicans. Among them, C-and N-terminal protected linear peptides were found to show the most potent AmB-potentiating activity.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Scheme 1
Scheme 2
Scheme 3
Fig. 1
Scheme 4

Similar content being viewed by others

References

  1. Liu W, Yuan L, Wang S. Recent progress in the discovery of antifungal agents targeting the cell wall. J Med Chem. 2020;63:12429–59.

    Article  CAS  PubMed  Google Scholar 

  2. Liu N, Tu J, Dong G, Wang Y, Sheng C. Emerging new targets for the treatment of resistant fungal infections. J Med Chem. 2018;61:5484–511.

    Article  CAS  PubMed  Google Scholar 

  3. Bongomin F, Gago S, Oladele RO, Denning DW. Global and Multi-national prevalence of fungal diseases-estimate precision. J Fungi (Basel). 2017;3:57.

    Article  PubMed  Google Scholar 

  4. Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. Hidden Killers: Human Fungal Infections. Sci Transl Med. 2012;4:165rv13.

    Article  PubMed  Google Scholar 

  5. Fukuda T, Nagai K, Yagi A, Kobayashi K, Uchida R, Yasuhara T, Tomoda H. Nectriatide, a potentiator of amphotericin B activity from Nectriaceae sp. BF-0114. J Nat Prod. 2019;82:2673–81.

    Article  CAS  PubMed  Google Scholar 

  6. Uchida R, Kondo A, Yagi A, Nonaka K, Masuma R, Kobayashi K, Tomoda H. Simpotentin, a new potentiator of amphotericin B activity against Candida albicans, produced by Simplicillium minatense FKI-4981. J Antibiot. 2019;72:134–40.

    Article  CAS  Google Scholar 

  7. Yagi A, Uchida R, Kobayashi K, Tomoda H. Polyketide glycosides phialotides A to H, new potentiators of amphotericin B activity, produced by Pseudophialophora sp. BF-0158. J Antibiot. 2020;73:211–23.

    Article  CAS  Google Scholar 

  8. Yagi A, Yamaguchi Y, Kawasaki K, Usui E, Yamazaki H, Uchida RH. New piericidin rhamnosides as potentiators of amphotericin B activity against Candida albicans produced by actinomycete strain TMPU-A0287. J Antibiot. 2023;76:65–74.

    Article  CAS  Google Scholar 

  9. Bartoli G, Bosco M, Carlone A, Dalpozzo R, Locatelli M, Melchiorre P, Sambri L. Alcohols and di-tert-butyl dicarbonate: How the nature of the Lewis acid catalyst may address the reaction to the synthesis of tert-butyl ethers. J Org Chem. 2006;71:9580–8.

    Article  CAS  PubMed  Google Scholar 

  10. Sato R, Oyama K, Konno H. Investigation for the cyclization efficiency of linear tetrapeptides: Synthesis of tentoxin B and dihydrotentoxin. Tetrahedron. 2018;74:6173–81.

    Article  CAS  Google Scholar 

  11. Doi R, Shibuya M, Murayama T, Yamamoto Y, Iwabuchi Y. Development of an azanoradamantane-type nitroxyl radical catalyst for class-selective oxidation of alcohols. J Org Chem. 2015;80:401–13.

    Article  CAS  PubMed  Google Scholar 

  12. Leggio A, Belsito EL, De Marco R, Liguori A, Perri F, Viscomi MC. An efficient preparation of N-methyl-α-amino acids from N-nosyl-α-amino acid phenacyl esters. J Org Chem. 2010;75:1386–92.

    Article  CAS  PubMed  Google Scholar 

  13. Clinical and Laboratory Standards Institute (CLSI): Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard CLSI document M38-A2. 3rd edition. Wayne, PA: Clinical and Laboratory Standards Institute; (2008).

Download references

Acknowledgements

This study was supported by JSPS KAKENHI Grant Number JP19K05719 (KN), JP22K05333 (KN) and JP21K15284 (KK), The Tokyo Biochemical Research Foundation (now Chugai Foundation for Innovative Drug Discovery Science: C-FINDs) (KK), The Research Foundation for Pharmaceutical Sciences (KK) and Kitasato University Research Grant for Young Researchers (KK).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kenichiro Nagai.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nagai, K., Kobayashi, K., Miyake, R. et al. Synthesis and biological evaluation of nectriatide derivatives, potentiators of amphotericin B activity. J Antibiot 77, 214–220 (2024). https://doi.org/10.1038/s41429-023-00700-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41429-023-00700-4

Search

Quick links